Nothing found. Try the Latin name or the product name.
Search
Nothing found. Try the Latin name or the product name.
Enroxil Flavour
Enrofloxacin · KRKA-Farma d.o.o.
1 form: scored tablet. In force in Georgia: 1 of 1 (veterinary register).
Forms and doses1 of 1 in force in Georgia
The dose from the product's label, by species and weight. Check the label of the pack you use.
| Form | Species | Dose | Frequency | Georgia | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50 mg, Scored tablet · Dog | Dog | 1 tablet per 10 kg Enrofloxacin 5 mg/kg/day PO: one 50 mg tablet per 10 kg body weight daily, with or without food. Measure body weight accurately and do not exceed the dose. Extend beyond 10 days only after clinical reassessment and veterinary judgement. The tablet is validated for halves only: one half is 25 mg and fits a 5 kg step at this regimen. Return a half-tablet to the opened blister and use within 24 hours; do not infer quartering or crushing accuracy. |
once daily or the daily amount divided into two administrations, for 5-10 days |
Georgia
Yes, veterinary
Veterinary (National Food Agency)
In the register: ენროქსილ ფლეივორი 50 მგ
№ 162-11; 15-11
Verified on: 22 Oct 2026 |
||||||||||||
Details: pack, label wording, sources, registrationenrofloxacin 50 mg, scored tablet for dogs Composition / strength
Enrofloxacin50 mg
Formulation Type Scored tablet Administration route By mouth Manufacturer KRKA-Farma d.o.o. · Croatia Registration
Georgia
Yes, veterinary
Veterinary (National Food Agency)
In the register: ენროქსილ ფლეივორი 50 მგ
№ 162-11; 15-11
Verified on: 22 Oct 2026 № UP/I-322-05/20-01/513
Verified on: 22 Oct 2026 Verified on: 22 Oct 2026 Controlled in Georgia
No
Checked against the narcotics law, Annex 1, lists I-IV, and Order No. 22/n.
Verified on: 16 Oct 2026
Information not fully verified
Prescription-only reserve fluoroquinolone. For diagnosed susceptible infections within the authorised dog scope when enrofloxacin is the justified choice, preferably supported by culture/susceptibility. Give 5 mg/kg/day PO for 5-10 days, once daily or as the daily amount divided twice, with or without food. One 50 mg tablet/10 kg; halves only. Weigh accurately, reassess before extending and use a returned blistered half within 24 hours.
| ||||||||||||||||
Known Contraindications
-
Critical
Do not use enrofloxacin in animals with epilepsy, seizures, or seizure disorders associated with the central nervous system, because it may stimulate the CNS.Sources: VMD SPC · VMD · FDA
-
Critical
Do not use in animals hypersensitive to the active substance, another fluoroquinolone, or any excipient. Do not use against known quinolone resistance because cross-resistance is extensive. Treat Pseudomonas infections only after susceptibility testing.Sources: VMD SPC · VMD
-
Critical
(Dog) Not for use in dogs less than 1 year of age or in exceptionally large breeds of dog with a longer growth period under 18 months of age. has not been establishedSources: VMD · FDA
-
Warning
Elimination may be delayed in animals with pre-existing renal damage. Use with caution in severe renal or hepatic impairment.Sources: VMD SPC · VMD
-
Warning
Use with caution in severe hepatic impairment. Concomitant administration with other hepatically metabolized medicines may reduce clearance of both the quinolone and the other medicine.Sources: VMD SPC · VMD · FDA
-
Warning
The use is not recommended during pregnancy The safety of the veterinary medicinal product has not been established during pregnancy and lactation Safety in breeding or pregnant cats has not been established The veterinary medicinal product may be used safely in pregnant and lactating animalsSources: VMD · FDA
-
Warning
the use is not recommended during lactation may be used safely in pregnant and lactating animalsSources: VMD
Known Drug Interactions
-
Major warning
Enrofloxacin + Aminophylline
Theophylline metabolism is inhibited by erythromycin, cimetidine, propranolol, enrofloxacin, and marbofloxacinRecommendation: Reduce the aminophylline dose during concomitant use. Signs of toxicity include vomiting, excitation, tachyarrhythmia, and seizures.Sources: MSD Vet Manual
-
Major warning
Enrofloxacin + Doxycycline
Do not combine enrofloxacin with antimicrobials that act antagonistically to quinolones, including macrolides, tetracyclines such as doxycycline, and phenicols such as chloramphenicol.Recommendation: Do not administer concurrently. Based on susceptibility testing, choose either a bactericidal fluoroquinolone or a bacteriostatic tetracycline.Sources: VMD SPC · VMD
-
Major warning
Enrofloxacin + Theophylline
Do not use concurrently with theophylline as the elimination of theophylline may be delayed Concomitant administration of theophylline requires careful monitoring as serum levels of theophylline may increaseRecommendation: Avoid the combination where possible. If concomitant use is unavoidable, monitor serum theophylline and be prepared to reduce its dose.Sources: VMD
-
Minor warning
Enrofloxacin + Sucralfate
The concomitant administration of substances containing magnesium or aluminium may reduce the absorption of enrofloxacin. These drugs should be administered two hours apart.Recommendation: Separation is not critical in dogs, but a 2-hour interval is safe and label-consistent. No comparable measurement exists in cats; use a 2-hour interval in cats.Sources: VMD SPC · VMD · JVIM
Professional reference for veterinary professionals. Not advertising and not a substitute for the product label/SPC.
For veterinary professionals only. It does not replace clinical judgement or the product label; check the dose in the official label (SPC). vetman is not liable for harm caused by using this information.
Trademarks belong to their owners; vetman is not affiliated with the manufacturers and receives no payment from them.
The database is protected under Chapter VII of the Law of Georgia on Copyright and Related Rights; automated or bulk copying is prohibited.
This reference is still growing. Missing a product? Let us know. · Report an error or request an addition · Updated: 23 Oct 2026